Cyclosporine for Moderate-to-Severe Alopecia Areata: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety

    Vivien Wai Yun Lai, Gang Chen, Douglas L. Gin, Rodney Sinclair
    TLDR Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.
    A double-blind, randomized, placebo-controlled trial evaluated the efficacy of cyclosporine in 32 adults with moderate-to-severe alopecia areata over 3 months. The cyclosporine group showed a higher proportion of participants achieving at least a 50% reduction in Severity of Alopecia Tool score (31.3% vs 6.3%) and improvements in eyelash (18.8% vs 0%) and eyebrow (31.3% vs 0%) scales compared to placebo. However, these differences did not reach statistical significance. The study's small sample size and single-institution setting limited the generalizability of the results.
    Discuss this study in the Community →

    Cited in this study

    7 / 7 results

    Related

    1 / 1 results